Clinical Trials Sponsored by Community LIFE

Total 1941 results

Bioniche Life Sciences Inc.

Terminated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer (EMBARC-RF)

Carcinoma in Situ | Neoplasm Recurrence, Local | Bladder Neoplasm | Mycobacterium | Transitional Cell, Carcinoma

United States, Canada, Poland, Germany, Netherlands, United Kingdom
Life Molecular Imaging SA

Terminated

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Prostate Cancer

Austria, Finland
Suven Life Sciences Limited

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects

Cognitive Disorders

United States
Life Molecular Imaging SA

Completed

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

Alzheimer Disease

United States, France, Japan, Australia, Germany
Life Extension Foundation Inc.

Completed

Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
SK Life Science, Inc.

Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy

Painful Diabetic Neuropathy

United States
SK Life Science, Inc.

Completed

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
Bioniche Life Sciences Inc.

Withdrawn

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Bladder Cancer

United States
Life Molecular Imaging SA

Completed

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Alzheimer Disease | Amyloid Beta-Protein

Australia
Life Molecular Imaging SA

Completed

Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.

Down Syndrome | Amyloid Beta-protein

United States
Alltech Life Sciences Inc.

Completed

Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress

Oxidative Stress

United States
SK Life Science, Inc.

Completed

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Epilepsy | Epilepsies, Partial | Epilepsy, Complex Partial | Complex Partial Seizures
SK Life Science, Inc.

Completed

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Epilepsy, Complex Partial | Epilepsy, Partial, Motor | Epilepsy, Simple Partial | Focal Motor Epilepsy
SK Life Science, Inc.

Completed

A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

Epilepsy, Complex Partial | Epilepsy, Partial, Motor | Epilepsy, Simple Partial | Focal Motor Epilepsy
SK Life Science, Inc.

Completed

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Epilepsy | Epilepsies, Partial
Life Molecular Imaging SA

Completed

PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers

Diagnostic Imaging

Austria, United States
Life Molecular Imaging SA

Completed

Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers

Diagnostic Imaging

Sweden, Finland
SK Life Science, Inc.

Completed

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Epilepsy | Epilepsy, Complex Partial | Seizure Disorder | Complex Partial Seizures | Epilepsy, Focal
Afexa Life Sciences Inc

Terminated

GLU-xx Formulations in Individuals With Impaired Glucose Tolerance

Impaired Glucose Tolerance

United States
Afexa Life Sciences Inc

Withdrawn

Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

United States
Sprim Advanced Life Sciences

Terminated

Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia

IBS-D and Functional Dyspepsia

United States
Afexa Life Sciences Inc

Completed

A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Advanced Life Sciences, Inc.

Completed

Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia

Pneumonia

United States
Advanced Life Sciences, Inc.

Unknown

Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma

Melanoma

United States
Clinical Life Sciences Ltd.

Completed

Effect of Plant Stanol Esters on Blood Lipids

Elevated Blood Lipids

Finland
ReAlta Life Sciences, Inc.

Not yet recruiting

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease (AURORA)

Steroid Refractory GVHD
Power Life Sciences Inc.

Not yet recruiting

Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research

Peripheral Neuropathy

United States
Power Life Sciences Inc.

Not yet recruiting

Assessing Patient Engagement in Keratoconus Clinical Research

Keratoconus

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Trends of Scleroderma Clinical Trials

Scleroderma

United States
Power Life Sciences Inc.

Not yet recruiting

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Tardive Dyskinesia

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Study Experiences of People With Anorexia Nervosa

Anorexia Nervosa

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Hepatic Encephalopathy

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients

Weight Loss

United States
Power Life Sciences Inc.

Not yet recruiting

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Recurrent Prostate Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Insights Into Participating in Studies for Bone Cancer

Bone Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Recurrent Ovarian Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

Liposarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Engagement Trends in Chondrosarcoma Clinical Trials

Chondrosarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Patterns in Social Anxiety Studies

Social Anxiety

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Endometrial Cancer Patients

Endometrial Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Insights Into Participating in Studies for Uterine Cancer

Uterine Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Borderline Personality Disorder Clinical Trial Experiences

Borderline Personality Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Neuroendocrine Tumors

United States
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Research Process for Glioma

Glioma

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating Factors In Study Experiences of Lymphedema Patients

Lymphedema

United States
Power Life Sciences Inc.

Not yet recruiting

Assessment of Schizophrenia Patients' Clinical Study Experiences

Schizophrenia

United States
Power Life Sciences Inc.

Not yet recruiting

Studying Patient Experiences in Osteoporosis Clinical Trials

Osteoporosis

United States
Power Life Sciences Inc.

Not yet recruiting

Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension

Pulmonary Hypertension

United States
Power Life Sciences Inc.

Not yet recruiting

A Detailed Look At What Patients Experience When They Take Part In Hypertension Clinical Trials

Hypertension

United States
Power Life Sciences Inc.

Not yet recruiting

Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials

Rectal Cancer

United States

3

Subscribe